The mitochondrial common deletion in Parkinson's disease and related movement disorders

Parkinsonism and Related Disorders

Volumn 8, Issue 3, 2002, Pages 165-170

  Zhang, J ^a   Montine, T J ^a   Smith, M A ^b   Siedlak, S L ^b   Gu, G ^a   Robertson, D ^a   Perry, G ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Aging; Energy metabolism; Free radicals; Mitochondria; Oxidative stress; Parkinsonism

Indexed keywords

FREE RADICAL; MITOCHONDRIAL DNA;

AGING; ARTICLE; AUTOPSY; CHIMERA; CONTROLLED STUDY; DEMENTIA; ENERGY METABOLISM; FEMALE; GENE DELETION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LEWY BODY; MALE; MESENCEPHALON; MITOCHONDRION; MOTOR DYSFUNCTION; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SUBSTANTIA NIGRA;

ADOLESCENT; ADULT; AGED; AGING; CADAVER; CHILD; DNA, MITOCHONDRIAL; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION; MESENCEPHALON; MIDDLE AGED; MOVEMENT DISORDERS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE;

EID: 0036131896     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(01)00041-4     Document Type: Article

References (29)

1. Disorders of movement and system degeneration
2. Free radicals and mitochondrial dysfunction in Parkinson's disease
3. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease
4. Mitochondrial DNA and Parkinson's disease
5. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes
6. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease
7. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family
8. Point mutations of mitochondrial genome in Parkinson's disease
9. Origin and functional consequences of the complex I defect in Parkinson's disease
10. Genetic and environmental risk factors in Parkinson's disease
11. The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality
12. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate
13. Mitochondrial genetics: a paradigm for aging and degenerative diseases?
14. Replication of animal mitochondrial DNA
15. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
16. Deletions of muscle mitochondrial DNA in mitochondrial myopathies: sequence analysis and possible mechanisms
17. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence
18. Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis
19. Quantitation of a mitochondrial DNA deletion in Parkinson's disease
20. The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction
21. Specific detection of deleted mitochondrial DNA by in situ hybridization using a chimera probe
22. Mitochondrial abnormalities in Alzheimer's disease
23. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
24. MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport
25. Mechanisms of MPTP toxicity
26. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons
27. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease
28. Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation